课题基金 / 基金详情

IN-VIVO FUNCTIONAL ONCO-IMAGING (SHARED RESOURCE)

IN-VIVO FUNCTIONAL ONCO-IMAGING (SHARED RESOURCE)
体内功能性肿瘤成像(共享资源)
批准号:
7944555
负责人:
Min-Ying L. Su
金额:
$4.2万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-06 至 2012-01-31

项目摘要

项目成果

Min-Ying L. Su的其他基金

相似基金

相关文献

中文摘要
翻译
体内功能性肿瘤成像(IVFOI)共享资源(SR)的目的是增强和支持 基础和临床癌症研究人员,为他们提供必要的专业知识,成像, 仪器和图像分析技术。本供资周期的主要成果是:1) 建立几个多模态成像系统,以支持创新的成像研究;以及2)提供 为转化临床研究提供高质量的图像采集和数据分析服务。在下一个周期中 我们将继续沿着这些领域发展,以支持研究人员的各种科学需求。 Chao Family Comprehensive Cancer Center(CFCCC)进行体内成像研究。 目前可用的系统包括三种MRI扫描仪(3 T-人体,4 T-人体和动物,以及7 T动物), 以及用于动物和人的组合的MRI-DOT(漫射光学层析成像)系统。的4 t MRI扫描仪为开发新的成像方法以及为 第二模态如DOT的集成以形成组合系统。二维荧光和X射线 目前一些癌症中心成员正在使用的系统将由IVFOI管理。一个3D模型 建立了与微型CT集成的荧光生物发光层析成像系统。这些 系统将支持CFCCC成员在设计创新成像组件方面的各种需求, 他们的研究,提供解剖和功能信息。共享资源还将支持 翻译临床研究,具有精确的方案执行和高标准的质量控制。的SR 一直在支持收集900多个具有统一协议的乳腺MRI研究,因此, 已经收集了大量的数据。在下一个周期,我们将继续支持此类临床研究, 还支持使用开发的多模态成像系统的转化临床研究,例如, 评价组合式MRI-DOT系统对乳腺癌的诊断性能。 总的来说,IVFOI将为CFCCC成员提供现成的最先进的技术, 为实验设计和成像方案以及图像采集和数据分析提供咨询, 以及各个项目之间的协调。通过共享成像和分析协议,我们将 能够整合从不同项目获得的各种信息,以促进未来的合作 在CFCCC成员之间,将基础科学家和临床研究人员聚集在一起, 进行临床转化研究。
英文摘要
The aim of the In-Vivo Functional Onco-lmaging (IVFOI) Shared Resource (SR) is to enhance and support basic and clinical cancer researchers by providing them with the necessary expertise, imaging instrumentation, and image analysis techniques. The major achievements during this funding cycle are: 1) establishing several multi-modality imaging systems to support innovative imaging studies; and 2) providing high-quality image acquisition and data analysis services for translational clinical studies. In the next cycle we will continue to develop along these areas to support various scientific needs of the investigators at the Chao Family Comprehensive Cancer Center (CFCCC) in performing in-vivo imaging studies. The current available systems include three MRI scanners (3T- human, 4T- human and animal, and 7Tanimal), and a combined MRI-DOT (diffuse optical tomography) system for both animal and human. The 4T MRI scanner provides an open architecture for development of new imaging methods, as well as for integration of the second modality such as DOT to form a combined system. A 2D Fluorescence & X-ray system currently being used by some Cancer Center Members will be managed by IVFOI. A prototype 3-D fluorescence & bioluminescence tomography system integrated with a micro CT has been built. These systems will support various needs of CFCCC Members in designing innovative imaging components into their studies, providing anatomical and functional information. The Shared Resource will also support translational clinical studies, with a precise protocol execution and a high standard quality control. The SR has been supporting the collection of more than 900 breast MRI studies with unified protocols, and as such a large database has been collected. In the next cycle we will continue to support such clinical studies, and also to support translational clinical research using the developed multi-modality imaging system, such as to evaluate the diagnostic performance of the combined MRI-DOT system for breast cancer. Overall, the IVFOI will provide CFCCC Members with ready access to state-of-the-art technologies, consultation for design of experiments and imaging protocols, and image acquisition and data analysis, as well as coordination among individual projects. Through the sharing of imaging and analysis protocol, we will be able to integrate various information obtained from different projects to facilitate future collaboration between CFCCC Members and to bring together basic scientists and clinical researchers to design and conduct clinical translational studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predicting Neoadjuvant Chemo Response/Prognosis Using Imaging Biomarkers
  • 批准号:
    8642609
  • 项目类别:
  • 资助金额:
    $48.48万
  • 财政年份:
    2008
  • 负责人:
    Min-Ying L. Su
  • 依托单位:
Predicting Neoadjuvant Chemo Response/Prognosis Using Imaging Biomarkers
  • 批准号:
    8835059
  • 项目类别:
  • 资助金额:
    $50.02万
  • 财政年份:
    2008
  • 负责人:
    Min-Ying L. Su
  • 依托单位:
Prediction of Neoadjuvant Chemo Pathological Response Using MRI Markers
  • 批准号:
    8018496
  • 项目类别:
  • 资助金额:
    $49.32万
  • 财政年份:
    2008
  • 负责人:
    Min-Ying L. Su
  • 依托单位:
Prediction of Neoadjuvant Chemo Pathological Response Using MRI Markers
  • 批准号:
    7599240
  • 项目类别:
  • 资助金额:
    $50.3万
  • 财政年份:
    2008
  • 负责人:
    Min-Ying L. Su
  • 依托单位:
海外基金